medications

Syndicate content

Medication may provide some benefit for older adults with anxiety disorder

Preliminary research suggests that use of the drug escitalopram provided some improvement in symptoms for older adults with generalized anxiety disorder, although the overall benefits were diminished because of nonadherence to the drug by some patients, according to a study in the January 21 issue of JAMA.

Get the full story...

Disclosure of medication can save a patient's life

Do you regularly take aspirin or antiplatelet medications? Do you know whether or not these drugs should be stopped before dental procedures or surgeries? According to a study published in the May/June issue of General Dentistry, the clinical, peer-reviewed journal of the Academy of General Dentistry (AGD), stopping antiplatelet medications prior to a surgical procedure places a patient at greater risk of permanent disability or death.

Get the full story...

Higher co-payments reduce use of antidepressants

As they struggle to contain skyrocketing medication costs, health plans across the U.S. have responded by implementing multi-tiered formularies requiring higher copayments for 'non-preferred' medications.

Get the full story...

Aging Institute Funds Smartphone Service for Medication

The program by the National Institute of Aging hopes that the smartphone technology should improve compliance with taking prescription drugs for the elderly and disease management.

Get the full story...

Sweden: Those in Debt Denied Medication

Sweden’s pharmacy monopoly has all but given up on being paid the US$ 46.7 million it’s owed by customers who have charged their medications.

Get the full story...

Rituxan may be called new drug for MS

Doctors are encouraged by the results of a new study using a medication called Rituxan to help patients with multiple sclerosis (MS).

Get the full story...

Study of successful drug targets could hasten development of new medications

Guidance from an innovative computational approach could speed up the process and cut down the cost of new drug development, researchers from the University of Chicago Medical Center and Columbia University suggest in a study to be published in the February 2008 issue of Genome Research, available early online.

Get the full story...

China bans advertisements exaggerating drug benefits

The State Food and Drug Administration in China ordered its local branches to assure the medication-producing companies remove the ads exaggerating the positive effects of their products.

Get the full story...

Pediatricians warn: cold medications may be harmful

American Academy of Pediatrics announced that cold and cough medications should be relabeled. Parents must know that the medications do not work in children under 6 and may be dangerous.

Get the full story...

Medication 'may have killed' arthritis patient

An inquest into the death of a 63-year-old Sydney woman has been told the medication she was prescribed for her arthritis may have been a factor in her death.

Get the full story...

Patients can't recall their medications to tell doctors

Doctors rely on patients to accurately tell them what prescription medications – and what dosages -- they are taking in out-patient visits. (A patient's chart may not always be available or complete.) That information is essential for physicians to monitor whether a drug is working, and whether it may have adverse interactions with any new medications prescribed.

Get the full story...

ECLIPSE data on effects of Otsuka's investigational novel treatment

A single dose of Otsuka’s investigational oral medication tolvaptan, a vasopressin receptor antagonist, resulted in favorable changes in hemodynamics associated with a significant increase in urine output in patients with advanced heart failure who participated in the international trial the EffeCt of ToLvaptan on HemodynamIc Parameters in Subjects with HEart failure, presented at the late breaking trials symposium of the Heart Failure Society of America’s Annual Scientific Meeting.

Get the full story...